# FDA Inspection 1209868 - OneBlood, Inc. - June 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/4beca3ab-ed4a-4ee3-8104-9e9b969dd4bf
Source feed: FDA_Inspections

> FDA Inspection 1209868 for OneBlood, Inc. on June 26, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209868
- Company Name: OneBlood, Inc.
- Inspection Date: 2023-06-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1275353 - 2025-07-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/6d85a39a-4b33-4f77-bb78-4e058a2f52aa)
- [FDA Inspection 1275353 - 2025-07-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/e8a0fb3f-3636-4cf7-b576-48e684969c22)
- [FDA Inspection 1111727 - 2019-10-16](https://www.keypedia.com/records/fda_inspections/oneblood-inc/32ec906c-0d87-40fe-a3f2-4f65c105b5f3)
- [FDA Inspection 1028091 - 2017-08-18](https://www.keypedia.com/records/fda_inspections/oneblood-inc/1f8b873f-a273-4352-b353-59e87c585779)
- [FDA Inspection 939189 - 2015-08-21](https://www.keypedia.com/records/fda_inspections/oneblood-inc/4c4abd21-3bd3-478b-93a2-488450273164)

Company: https://www.keypedia.com/companies/oneblood-inc/9acbf4c9-9511-489b-920c-b83d786b09e0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d